StockWatch
·
Misc Health and Biotechnology Services
BuybackMay 26, 2026, 09:17 AM

Progyny Board Approves $200M Share Repurchase Program

AI Summary

Progyny, Inc. announced that its Board of Directors has authorized a share repurchase program for up to $200 million of its common stock. The program will be funded using the company's available cash balances. Repurchases may occur through open market transactions, including Rule 10b5-1 plans, and are subject to market conditions and the company's sole discretion.

Key Highlights

  • Progyny's Board of Directors approved a share repurchase program.
  • The program authorizes repurchases of up to $200 million of common stock.
  • The share repurchase program will be funded through available cash balances.
  • Shares may be repurchased through open market transactions, including Rule 10b5-1 plans.
  • The program may be suspended or discontinued at any time at the company's discretion.